Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
about
Regulation of T cell motility in vitro and in vivo by LPA and LPA2Lysophospholipid receptors in drug discovery.Autotaxin: structure-function and signalingDecreased peritoneal ovarian cancer growth in mice lacking expression of lipid phosphate phosphohydrolase 1.Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody responseProteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication.Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasisUncovering unique roles of LPA receptors in the tumor microenvironment.Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5.Extracellular Matrix Rigidity-dependent Sphingosine-1-phosphate Secretion Regulates Metastatic Cancer Cell Invasion and AdhesionDown-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma.Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index.Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects.Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation-Novel Paradigm and Therapeutic PotentialProteotranscriptomics Reveal Signaling Networks in the Ovarian Cancer Microenvironment.Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.Extracellular Vesicles as Conveyors of Membrane-Derived Bioactive Lipids in Immune System.
P2860
Q27320538-EBDDB4A3-B78B-4CF6-9152-334A5ABC4FA9Q27692680-4C9432B5-044A-43AA-8ED2-679779DB8197Q28307790-4C6D006F-355D-4FA5-8500-5F34A56DC561Q30300375-940D2DE8-A05F-42D2-95B9-2FB047529164Q34025718-2A7EB715-1F5F-4698-9434-D93256536081Q34634997-3C321D0B-784E-4DCB-B235-11D43C85EBB4Q34980426-D21A967C-3544-4632-8E67-7ECE794310AFQ35628694-6443BDF8-C3AA-4B34-93A8-885FEFB7AB20Q35904954-5F9D3163-4D5F-44C4-ABCF-501476BCB21DQ36579672-4FDDF5DA-F4B6-45F2-AFD9-D53DFDD5FEC4Q38949843-2910A57B-60E1-41CA-B498-6BB4274CD78EQ39237720-DCA9EE8D-2EA3-4B3D-8453-2FEA2297A95BQ39511975-ABB8DA7F-1CE2-4972-A63E-B073BF2F87D7Q39732801-9D8E5AEB-20A2-4A97-87BE-B7B7FA62B151Q47398937-EBA07748-D010-4B0D-B7BC-4ED6FBFB441EQ50074055-9494CC36-DEB3-445E-BA92-CF5CBAE278E9Q52316727-503B4EDF-B1F5-4C57-B76A-8577F908D9AE
P2860
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
@en
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
@nl
type
label
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
@en
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
@nl
prefLabel
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
@en
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
@nl
P2093
P2860
P1476
Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
@en
P2093
Amin Al-Shami
Gabor Tigyi
Pamela Strauch
Raul M Torres
Roberta Pelanda
Shannon K Oda
Tamas Oravecz
Yuko Fujiwara
P2860
P304
P356
10.1158/2326-6066.CIR-13-0043-T
P577
2013-10-01T00:00:00Z